CD4 and neoplasm: Additionally, in comparison to that in the tumor-bearing control group, the percentages of CD4+ Th1 cells in the CTT group were clearly elevated in the spleen and blood, and the percentage of splenic CD4+ Th2 cells was also increased (Figure 1M).